50% off Premium Yearly

NYSE:G
This summary was created by AI, based on 3 opinions in the last 12 months.
Genpact Ltd (G-N) has been a strong performer historically, having achieved earnings growth of 13% over the past 15 years. However, it has recently faced a downturn, losing about 20% this year amid concerns surrounding artificial intelligence, which some analysts believe are unfounded. The stock currently trades at a relatively low price-to-earnings ratio of 9.7x and offers a free cash flow yield of 8.5%, indicating potential for value. Despite its growth potential in banking and insurance services, experts are suggesting caution as the stock has triggered stop-loss levels and is seen as stagnating. It may be a good time to reassess positions in light of recent performance.
Genpact Ltd is a American stock, trading under the symbol G (previously G-N on Stockchase) on the New York Stock Exchange (G). It is usually referred to as NYSE:G or G
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on G (previously G-N on Stockchase). 3 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is PAST TOP PICK. Read the latest stock experts' ratings for Genpact Ltd.
Genpact Ltd was recommended as a Top Pick by Bill Carrigan on 2009-08-28. Read the latest stock experts ratings for Genpact Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Genpact Ltd.
Genpact Ltd is covered by Stockchase experts and is worth watching.
On 2026-08-21, Genpact Ltd (G) stock closed at a price of $37.14.